Absci Corporation

ABSI·NasdaqGS·Healthcare
Compare
10.48+0.48 (+4.80%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market10.44−0.04 (−0.38%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.00
Open10.26
Day range9.7810.68
52-week range2.2412.55
Off day high−1.87%
Off 52-week high−16.46%
Volume4.15M
Avg. volume (3M)3.64M
Market cap1.80B
EPS (TTM)-0.7900
Forward P/E-15.12
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.19
Shares outstanding171.61M
Short interest26.24% of float
Earnings dateNov 12, 2026
Analyst target14.82
Profit margin0.00%

Against its peers

Compare in full ›
ABSI RCUS IMNM XNCR ABCL 2256.HK
Market cap 1.80B 2.43B 2.30B 2.60B 3.98B 5.03B
P/E (TTM) — — — — — —
Forward P/E -15.1 -6.2 -7.9 -9.9 -16.1 -24.1
Price/book 7.3 3.8 4.2 4.0 4.2 2.0
Dividend yield — — — — — —
1-year change +191.92% −1.28% +25.94% +150.21% +171.08% −54.94%
Today +4.80% +2.12% −3.89% +14.33% +0.82% +6.85%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ABSI news ›
Defense World·Positive

Contrasting Absci (NASDAQ:ABSI) & Geron (NASDAQ:GERN)

Posted by Defense World Staff on Oct 25th, 2026 Absci (NASDAQ:ABSI – Get Free Report) and Geron (NASDAQ:GERN – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses…

TU News·Negative

Absci launches women cohort in ABS-201 hair loss trial

Traders Union Absci launches women cohort in ABS-201 hair loss trial Absci has announced the launch of a dedicated women cohort in its Phase 1/2a clinical trial for the ABS-201 program targeting pattern hair loss. The recent update,…

From the 4Search news index, newest first.

In the news

14mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance